KR100317902B1 - A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism - Google Patents
A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism Download PDFInfo
- Publication number
- KR100317902B1 KR100317902B1 KR1019990053495A KR19990053495A KR100317902B1 KR 100317902 B1 KR100317902 B1 KR 100317902B1 KR 1019990053495 A KR1019990053495 A KR 1019990053495A KR 19990053495 A KR19990053495 A KR 19990053495A KR 100317902 B1 KR100317902 B1 KR 100317902B1
- Authority
- KR
- South Korea
- Prior art keywords
- glutamic acid
- microorganism
- strain
- present
- mercaptopurine
- Prior art date
Links
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 title claims abstract description 20
- 235000013922 glutamic acid Nutrition 0.000 title claims abstract description 20
- 239000004220 glutamic acid Substances 0.000 title claims abstract description 20
- 244000005700 microbiome Species 0.000 title claims abstract description 18
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 11
- GLVAUDGFNGKCSF-UHFFFAOYSA-N mercaptopurine Chemical compound S=C1NC=NC2=C1NC=N2 GLVAUDGFNGKCSF-UHFFFAOYSA-N 0.000 claims abstract description 13
- 229960001428 mercaptopurine Drugs 0.000 claims abstract description 13
- 235000000346 sugar Nutrition 0.000 claims abstract description 12
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 11
- 239000008103 glucose Substances 0.000 claims abstract description 11
- 235000013379 molasses Nutrition 0.000 claims abstract description 9
- 241000186226 Corynebacterium glutamicum Species 0.000 claims abstract description 7
- 239000002699 waste material Substances 0.000 claims abstract description 5
- 229920002472 Starch Polymers 0.000 claims abstract description 3
- 239000008107 starch Substances 0.000 claims abstract description 3
- 235000019698 starch Nutrition 0.000 claims abstract description 3
- 235000001727 glucose Nutrition 0.000 claims abstract 2
- WZJYKHNJTSNBHV-UHFFFAOYSA-N benzo[h]quinoline Chemical compound C1=CN=C2C3=CC=CC=C3C=CC2=C1 WZJYKHNJTSNBHV-UHFFFAOYSA-N 0.000 claims description 4
- 238000012258 culturing Methods 0.000 claims description 2
- 238000007796 conventional method Methods 0.000 abstract description 3
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 abstract description 2
- 230000037353 metabolic pathway Effects 0.000 abstract description 2
- 230000035772 mutation Effects 0.000 abstract description 2
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 abstract description 2
- 239000002609 medium Substances 0.000 description 17
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 16
- 230000004151 fermentation Effects 0.000 description 15
- 238000000855 fermentation Methods 0.000 description 15
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 13
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 12
- 238000011218 seed culture Methods 0.000 description 11
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 8
- 239000004202 carbamide Substances 0.000 description 8
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 8
- 239000000243 solution Substances 0.000 description 7
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 6
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 6
- 235000011130 ammonium sulphate Nutrition 0.000 description 6
- 229910000358 iron sulfate Inorganic materials 0.000 description 6
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 6
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 6
- 235000019341 magnesium sulphate Nutrition 0.000 description 6
- 229940099596 manganese sulfate Drugs 0.000 description 6
- 239000011702 manganese sulphate Substances 0.000 description 6
- 235000007079 manganese sulphate Nutrition 0.000 description 6
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 6
- 229960000344 thiamine hydrochloride Drugs 0.000 description 6
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 6
- 239000011747 thiamine hydrochloride Substances 0.000 description 6
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 6
- 229960002685 biotin Drugs 0.000 description 5
- 235000020958 biotin Nutrition 0.000 description 5
- 239000011616 biotin Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 241000894007 species Species 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 4
- 108010080698 Peptones Proteins 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 230000037149 energy metabolism Effects 0.000 description 4
- 235000013882 gravy Nutrition 0.000 description 4
- 235000019319 peptone Nutrition 0.000 description 4
- 239000011780 sodium chloride Substances 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- BELBBZDIHDAJOR-UHFFFAOYSA-N Phenolsulfonephthalein Chemical compound C1=CC(O)=CC=C1C1(C=2C=CC(O)=CC=2)C2=CC=CC=C2S(=O)(=O)O1 BELBBZDIHDAJOR-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 3
- 238000004146 energy storage Methods 0.000 description 3
- 229960003531 phenolsulfonphthalein Drugs 0.000 description 3
- 229910000160 potassium phosphate Inorganic materials 0.000 description 3
- 235000011009 potassium phosphates Nutrition 0.000 description 3
- 150000003212 purines Chemical class 0.000 description 3
- 239000011232 storage material Substances 0.000 description 3
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 229930091371 Fructose Natural products 0.000 description 2
- 239000005715 Fructose Substances 0.000 description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 2
- 229930182555 Penicillin Natural products 0.000 description 2
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 108010073771 Soybean Proteins Proteins 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- 229930195712 glutamate Natural products 0.000 description 2
- UYTPUPDQBNUYGX-UHFFFAOYSA-N guanine Chemical compound O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000002503 metabolic effect Effects 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 229940049954 penicillin Drugs 0.000 description 2
- 239000003531 protein hydrolysate Substances 0.000 description 2
- 229940001941 soy protein Drugs 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- RYCLIXPGLDDLTM-UHFFFAOYSA-J tetrapotassium;phosphonato phosphate Chemical compound [K+].[K+].[K+].[K+].[O-]P([O-])(=O)OP([O-])([O-])=O RYCLIXPGLDDLTM-UHFFFAOYSA-J 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- -1 ATP and GTP Chemical class 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 235000011114 ammonium hydroxide Nutrition 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003016 phosphoric acids Chemical class 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/20—Bacteria; Culture media therefor
- C12N1/205—Bacterial isolates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/14—Glutamic acid; Glutamine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
- C12R2001/00—Microorganisms ; Processes using microorganisms
- C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
- C12R2001/15—Corynebacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
본 발명은 글루탐산을 생산하는 코리네박테리움 글루타미컴(Corynebacterium glutamicum) KFCC-10656을 모균주로 자외선조사, N-메틸-N`-니트로-N-니트로소구아니딘 (NTG) 등의 변이 유발제로 통상적인 방법에 따라 처리하여 모균주의 형질을 변형시켜, 머캅토퓨린(Mercaptopurine)내성을 가지게 함으로써 균주의 대사경로에 변화가 생겨서, 모균주에 비해 글루탐산 생산능이 향상된 변이주에 관한 것이다. 또한 이 변이주를 폐당밀, 포도당, 전분 가수분해물 및 원당 등이 포함된 배지중에서 배양하여 배양물로부터 글루탐산을 채취하는, 미생물을 이용한 글루탐산의 제조방법에 관한 것이다.The present invention is directed to mutations such as UV irradiation, N-methyl-N`-nitro-N-nitrosoguanidine (NTG) as a parent strain of Corynebacterium glutamicum KFCC-10656, which produces glutamic acid. The present invention relates to a mutant strain having a change in the metabolic pathway of the strain by modifying the trait of the parent strain by treating it according to a conventional method to have mercaptopurine resistance, thereby improving glutamic acid production ability as compared to the parent strain. The present invention also relates to a method for producing glutamic acid using microorganisms, wherein the mutant strain is cultured in a medium containing waste molasses, glucose, starch hydrolyzate, raw sugar, and the like to extract glutamic acid from the culture.
Description
본 발명은 글루탐산을 생산하는 미생물 및 이를 이용한 글루탐산의 제조방법에 관한 것으로, 좀더 구체적으로는 코리네박테리움 글루타미컴(Corynebacterium glutamicum) KFCC-10656의 변이주로서 머캅토퓨린(Mercaptopurine) 내성을 보유하며 이에 따른 대사경로상의 변화에 의해 기존 균주에 비해 글루탐산의 생산능이 향상된 미생물 및 이를 이용한 글루탐산의 제조방법에 관한 것이다.The present invention relates to a microorganism that produces glutamic acid and a method for preparing glutamic acid using the same, and more specifically, has a mercaptopurine resistance as a mutant strain of Corynebacterium glutamicum KFCC-10656. Accordingly, the present invention relates to a microorganism having improved production of glutamic acid, and a method for preparing glutamic acid using the same, by changes in metabolic pathways.
미생물들은 에너지 대사 과정에 있어서 에너지 저장물질로서 ATP, GTP등 고에너지 인산화합물들을 이용한다. 이러한 물질들은 에너지 대사과정에서 합성되고, 필요시 소모되어 에너지를 발생시키며 미생물의 대사에 중요한 역할을 한다. 따라서 ATP, GTP 등의 에너지 저장 물질들의 생성을 강화시키면, 미생물의 에너지 대사가 강화되어서 균체의 활성 또한 강화될 것으로 기대된다. 에너지 대사 활성의 증가는 물질 대사 과정의 전체적 흐름을 개선시켜 대사 산물들의 생성에도 영향을 미칠 것으로 생각되었다. ATP, GTP 등 고에너지 인산 화합물의 기본 물질인 아데닌 및 구아닌은 퓨린 화합물이며, 따라서 퓨린 유사체인 머캅토퓨린(Mercaptopurine)을 이용하면 퓨린계 에너지 저장물질인 ATP, GTP 등의 생성을 강화할 수 있을 것으로 생각되었다. 퓨린 유사체인 머캅토퓨린에 내성을 가지는 균주는 강화된 ATP, GTP 생성 플럭스를 보일 것으로 생각되었으며, 이러한 에너지 대사의 강화는 전체적인 대사 흐름을 원활하게 해서 목적 산물인 글루탐산의 생산 또한 증가시킬 수 있을 것으로 기대되었다.Microorganisms use high-energy phosphate compounds such as ATP and GTP as energy storage materials in energy metabolism. These substances are synthesized during energy metabolism, consumed as needed to generate energy, and play an important role in the metabolism of microorganisms. Therefore, by enhancing the production of energy storage materials such as ATP, GTP, it is expected that the energy metabolism of the microorganism is strengthened and the activity of the cells is also enhanced. Increasing energy metabolic activity was thought to improve the overall flow of the metabolism process and thus affect the production of metabolites. Adenine and guanine, which are basic substances of high-energy phosphoric acid compounds such as ATP and GTP, are purine compounds. Therefore, mercaptopurine, which is a purine analogue, can enhance the production of purine-based energy storage materials ATP and GTP. It was thought. Strains resistant to the purine analog, mercaptopurine, were expected to exhibit enhanced ATP and GTP production fluxes, and this enhanced energy metabolism could facilitate the overall metabolic flow and increase the production of glutamate, the desired product. Expected.
본 발명자들은 종래 미생물의 형질을 변형시켜서 머캅토퓨린에 내성을 갖게 하여 기존 균주에 비해 글루탐산 생산성이 향상된 변이주를 획득하여 본 발명을 완성하였다.The present inventors have completed the present invention by modifying the traits of conventional microorganisms to make mercaptopurine resistant to obtain a mutant strain with improved glutamic acid productivity compared to the existing strain.
본 발명의 미생물 SM5는 코리네박테리움 글루타미컴(Corynebacterium glutamicum) KFCC-10656을 모균주로하여 자외선조사, N-메틸-N`-니트로-N-니트로소구아니딘 (NTG) 등의 변이 유발제로 통상적인 방법에 따라 처리한 후, 머캅토퓨린이 농도별로 첨가된 배지[포도당 10 g/l, 인산제1칼륨 1 g/l, 인산제2칼륨 0.5g/l, 황산암모늄 0.5 g/l, 요소 1 g/l, 황산철 20 mg/l, 황산마그네슘 0.5 g/l, 황산망간 20 mg/l, 티아민염산염 200 ㎍/l, 비오틴 200 ㎍/l, 당밀 5 g/l, pH 7.0로 이루어진 최소배지에 머캅토퓨린 50-1000 mg/l을 첨가한 배지]에서 생육할 수 있는 변이주들 중에서 선별해낸 균주이다. 이때 사용된 배지중의 머캅토퓨린 농도는 1000 mg/l 까지였으며, 분리에 성공한 내성주는 400 mg/l 머캅토퓨린 농도에서 생육가능한 것으로 확인되었다.The microorganism SM5 of the present invention is a parent strain of Corynebacterium glutamicum KFCC-10656, which is used as a mutation causing agent such as UV irradiation, N-methyl-N`-nitro-N-nitrosoguanidine (NTG), etc. After treatment according to a conventional method, medium in which mercaptopurine was added at different concentrations [glucose 10 g / l, 1 g of potassium phosphate, 0.5 g / l of potassium diphosphate, 0.5 g / l of ammonium sulfate, Consisting of urea 1 g / l, iron sulfate 20 mg / l, magnesium sulfate 0.5 g / l, manganese sulfate 20 mg / l, thiamine hydrochloride 200 μg / l, biotin 200 μg / l, molasses 5 g / l, pH 7.0 Medium is a strain selected from among the mutant strains that can be grown in a medium with mercaptopurine 50-1000 mg / l added to the minimum medium. At this time, the concentration of mercaptopurine in the medium used was up to 1000 mg / l, and it was confirmed that the resistant strain that was successfully separated can be grown at the concentration of 400 mg / l mercaptopurine.
여기서 얻어진 변이주에 대해 플라스크 실험 및 발효조 배양 실험을 실시한 결과 기존 균주에 비해 글루탐산 생산성이 약 9% 정도 향상된 사실이 입증되었으며, 이 균주를 SM5라 명명하여 1999년 11월 2일에 KFCC-11112로 한국종균협회에 기탁하였다.Flask test and fermenter culture test of the mutant strains obtained here proved about 9% improvement in glutamic acid productivity compared to the existing strain.The strain was named SM5 and was designated as KFCC-11112 on November 2, 1999. It was deposited in the spawn association.
본 발명의 균주를 위해 사용된 영양배지는 펩톤 1, 육즙 1, 염화나트륨 0.25, 효모엑기스 1, 한천 2, pH 7.2로 구성된다.The nutrient medium used for the strain of the present invention is composed of peptone 1, gravy 1, sodium chloride 0.25, yeast extract 1, agar 2, pH 7.2.
본 발명에서 분리한 신규의 변이주 SM5의 생화학적 특성은 표1 및 표2의 기재와 같으며, 이들 내용에 의하면 본 발명의 미생물은 400 mg/l 농도의 머캅토퓨린 첨가배지에서도 생육 가능하다. 또한 이 균주는 α-나프토퀴놀린에도 높은 내성을 가지는 것으로 나타났는데, 이러한 특성은 균주의 산소 요구성이 낮아지는 것을 의미하며, 산소 공급이 부족한 조건하에서도 기존 균주에 비해 우수한 발효 능력을보일 것으로 생각된다.The biochemical properties of the novel mutant strain SM5 isolated from the present invention are as described in Table 1 and Table 2. According to these contents, the microorganism of the present invention can also be grown in a medium containing 400 mg / l mercaptopurine. In addition, this strain was shown to have a high resistance to α-naphthoquinoline, which means that the oxygen demand of the strain is lowered, and it is expected to show excellent fermentation ability compared to the existing strain even under conditions of insufficient oxygen supply. I think.
본 발명 미생물의 특성은 다음의 표에 기재된 바와 같다.The characteristics of the microorganism of the present invention are as described in the following table.
(주) +; 생육, -; 생육하지 못함, 30℃에서 72시간 배양.(Note) +; Growth,-; Not grown, incubated for 72 hours at 30 ° C.
(주) +; 생육, -; 생육하지 못함, 30℃에서 72시간 배양.(Note) +; Growth,-; Not grown, incubated for 72 hours at 30 ° C.
다음의 실시예에서 본 발명을 좀 더 구체적으로 설명한다.The present invention is explained in more detail in the following examples.
실시예 1Example 1
사용균주: 코리네박테리움 글루타미컴 KFCC-10656 및 본 발명의 미생물SM5(KFCC-11112).Use strain: Corynebacterium glutamicum KFCC-10656 and microorganism SM5 of the present invention (KFCC-11112).
종배지: 펩톤 1, 효모엑기스 0.5, 육즙 0.5, 포도당 1, 염화나트륨 0.25, 요소 0.13, pH 7.2.Species medium: peptone 1, yeast extract 0.5, gravy 0.5, glucose 1, sodium chloride 0.25, urea 0.13, pH 7.2.
발효배지: 포도당 3, 미액 0.2, 비오틴 1 ㎍/l, 폐당밀 0.05, 황산암모늄 0.1, 황산철 0.002, 황산 망간 0.002, 황산 마그네슘 0.05, 티아민 염산염 200 ㎍/l, 인산 제1칼륨 0.2, 요소 0.95, pH 7.2.Fermentation medium: glucose 3, liquid 0.2, biotin 1 μg / l, waste molasses 0.05, ammonium sulfate 0.1, iron sulfate 0.002, manganese sulfate 0.002, magnesium sulfate 0.05, thiamine hydrochloride 200 μg / l, potassium phosphate 0.2, urea 0.95 , pH 7.2.
발효방법: 상기 종배지 3 ml을 지름 18 mm 시험관에 분주하고 상법에 따라 가압 살균후 사용 균주를 접종하고 30℃에서 18시간 진탕 배양하여 종배양액으로 사용하였다. 발효배지 40 ml을 500 ml 진탕용 삼각플라스크에 분주하고 121℃에서 10분간 가압 살균하여 종배양액 1 ml을 식균한 다음 48시간 배양하였다. 회전수는 분당 180회, 30℃, pH 7.2로 조절하였다. 배양완료 후 배지내 글루탐산 축적량은 KFCC10656이 16.5 g/l, SM5가 17.8 g/l이었다.Fermentation method: 3 ml of the seed medium was dispensed into a test tube with a diameter of 18 mm, inoculated using strain after autoclaving according to a conventional method, and shaken for 18 hours at 30 ° C. to use as a seed culture solution. 40 ml of the fermentation broth was dispensed into a 500 ml shake flask for pressure and sterilized under pressure at 121 ° C. for 10 minutes to inoculate 1 ml of the seed culture solution and incubated for 48 hours. The rotation speed was adjusted to 180 times per minute, 30 ° C., pH 7.2. After incubation, the amount of glutamic acid in the medium was 16.5 g / l for KFCC10656 and 17.8 g / l for SM5.
본 실시예의 결과, 본 발명의 미생물은 기존 균주에 비해 당농도 3배지에서 글루탐산 생산성이 약 8정도 향상된 것으로 확인되었다.As a result of the present embodiment, the microorganism of the present invention was confirmed that the productivity of glutamic acid is improved by about 8 at a glucose concentration of 3 compared to the existing strain.
실시예 2Example 2
사용균주: 실시예 1과 동일Strains used: same as Example 1
1차 종배지: 펩톤 1, 효모 엑기스 0.7, 육즙 0.7, 포도당 1, 자당 1, 염화나트륨 0.25, 요소 0.3, 페놀레드 0.001, pH 7.2.Primary species: peptone 1, yeast extract 0.7, gravy 0.7, glucose 1, sucrose 1, sodium chloride 0.25, urea 0.3, phenol red 0.001, pH 7.2.
2차 종배지: 원당 3, 포도당 1, 과당 1, 황산 마그네슘 0.04, 인산 제1칼륨 0.1, 인산 제2칼륨 0.05, 황산 암모늄 0.8, 황산철 0.002, 황산망간 0.002, 황산아연 0.0002, 황산구리 0.0002, 비오틴 500 ㎍/l, 티아민 염산염 2 mg/l, 대두단백 가수분해물 0.2, 페놀레드 0.001, pH 6.8.Secondary species: raw sugar 3, glucose 1, fructose 1, magnesium sulfate 0.04, potassium monophosphate 0.1, dipotassium phosphate 0.05, ammonium sulfate 0.8, iron sulfate 0.002, manganese sulfate 0.002, zinc sulfate 0.0002, copper sulfate 0.0002, biotin 500 μg / l, thiamine hydrochloride 2 mg / l, soy protein hydrolyzate 0.2, phenol red 0.001, pH 6.8.
발효배지: 자당 6, 포도당 2, 과당 2, 황산 마그네슘 0.05, 인산 제1칼륨 0.05, 인산 제2칼륨 0.15, 황산 암모늄 0.1, 황산철 0.002, 황산망간 0.002, 황산아연 0.0002, 황산구리 0.0002, 비오틴 30 ㎍/l, 티아민 염산염 1 mg/l, 대두단백 가수분해물 0.2, 페놀레드 0.001, 탄산칼슘 3, pH 6.75.Fermentation medium: Sucrose 6, Glucose 2, Fructose 2, Magnesium sulfate 0.05, Potassium phosphate 0.05, Dipotassium phosphate 0.15, Ammonium sulfate 0.1, Iron sulfate 0.002, Manganese sulfate 0.002, Zinc sulfate 0.0002, Copper sulfate 0.0002, Biotin 30 ㎍ / l, thiamine hydrochloride 1 mg / l, soy protein hydrolyzate 0.2, phenol red 0.001, calcium carbonate 3, pH 6.75.
1차 종배양: 상기 1차 종배양 배지 2.5 ml을 18 mm 시험관에 분주하고 121℃에서 5분간 가압 살균하여 냉각한후 사용균주를 접종하고 30℃에서 분당 160회의 회전수로 12시간 진탕 배양하였다.Primary seed culture: 2.5 ml of the primary seed culture medium was dispensed into an 18 mm test tube, sterilized by autoclaving at 121 ° C. for 5 minutes, inoculated with the used strain, and incubated for 12 hours at 30 ° C. at 160 revolutions per minute. .
2차 종배양: 2차 종배지 30 ml을 250 ml 진탕용 삼각플라스크에 분주하고 121℃에서 5분간 가압 살균 후 냉각하여 1차 종배양액의 배양완료액을 1 ml 접종한 후 31℃에서 150 rpm으로 14시간 진탕 배양하였다.Secondary seed culture: 30 ml of secondary seed medium is dispensed into a 250 ml shaking Erlenmeyer flask, pressurized and sterilized at 121 ° C. for 5 minutes, cooled, inoculated 1 ml of the primary seed culture solution, and then 150 rpm at 31 ° C. Shaking culture for 14 hours.
발효방법: 상기 발효배지를 250 ml 삼각 플라스크에 30 ml씩 분주하고, 10요소 용액 1 ml을 첨가한 후 2차 종배양액 5 ml을 접종한 후, 31℃에서 150 rpm으로 36시간 배양하였다. 배양 중간에 pH에 따라 10요소수용액을 8 ml 수시로 첨가하여, pH 조절 및 질소원 공급을 하였다. 발효시작 2시간 후 계면 활성제 0.04와 페니실린 0.3 U/ml을 첨가한 후 당이 모두 소모될 때까지 배양하였다.Fermentation method: The fermentation broth was dispensed 30 ml each in a 250 ml Erlenmeyer flask, 1 ml of 10 urea solution was added, 5 ml of the secondary seed culture solution was inoculated, and then cultured for 36 hours at 150 rpm at 31 ° C. 10 ml of aqueous solution of urea was added from time to time depending on the pH in the middle of the culture, and pH adjustment and nitrogen supply were performed. After 2 hours from the start of fermentation, 0.04 of surfactant and 0.3 U / ml of penicillin were added and cultured until all of the sugar was consumed.
배양완료후 글루탐산의 농도는 KFCC-10656이 45.2 g/l, SM5가 50.6 g/l였다.The concentration of glutamic acid after incubation was 45.2 g / l for KFCC-10656 and 50.6 g / l for SM5.
실시예3Example 3
1차 종배지: 펩톤 0.7, 효모엑기스 0.7, 육즙 0.7, 포도당 1, 염화나트륨 0.25, 요소 0.13, 황산 암모늄 0.1, pH 7.5.Primary species: peptone 0.7, yeast extract 0.7, gravy 0.7, glucose 1, sodium chloride 0.25, urea 0.13, ammonium sulfate 0.1, pH 7.5.
2차 종배지: 원당 3, 당밀 1, 황산마그네슘 0.04, 인산제2칼륨 0.1, 황산 암모늄 0.3, 황산철 0.001, 황산망간 0.001, 비오틴 500 ㎍/l, 티아민 염산염 2 mg/l, 요소 0.1, pH 7.1.Secondary species: raw sugar 3, molasses 1, magnesium sulfate 0.04, potassium diphosphate 0.1, ammonium sulfate 0.3, iron sulfate 0.001, manganese sulfate 0.001, biotin 500 μg / l, thiamine hydrochloride 2 mg / l, urea 0.1, pH 7.1.
발효배지: 원당 1.7, 당밀 6.8, 인산 0.13, 황산마그네슘 0.04, 황산철 0.001, 황산망간 0.001, 미액 0.1, 티아민 염산염 200 ㎍/l, 수산화칼륨 0.18, 소포제 0.005, pH 7.5.Fermentation medium: raw sugar 1.7, molasses 6.8, phosphoric acid 0.13, magnesium sulfate 0.04, iron sulfate 0.001, manganese sulfate 0.001, fine liquid 0.1, thiamine hydrochloride 200 μg / l, potassium hydroxide 0.18, antifoam 0.005, pH 7.5.
1차 종배양: 1차 종배지 40 ml을 500 ml 진탕용 삼각 플라스크에 분주하고 121℃에서 10분간 가압 살균하여 냉각후 균주를 접종하여 회전수 분당 180회, 30℃에서 20시간 진탕 배양하였다.Primary seed culture: 40 ml of the primary seed medium was dispensed into a 500 ml shake Erlenmeyer flask, pressurized and sterilized at 121 ° C. for 10 minutes, inoculated with the strain after cooling, and incubated at 180 ° C. per minute for 20 hours at 30 ° C.
2차 종배양: 2차 종배지를 5리터 용량의 실험용 발효조에 2.5리터씩 분주하고 121℃에서 10분간 가압살균한후 냉각시켜 1차 종배양액의 배양완료액을 30 ml 접종한 후 공기를 배분당 0.5리터 공급하면서 900 rpm, 30℃에서 18시간 진탕 배양하였다.Secondary seed culture: Dispense the secondary seed medium into 2.5 liter each in a 5 liter experimental fermenter, pressurize and sterilize at 121 ℃ for 10 minutes, cool, inoculate 30 ml of the primary seed culture culture solution, and air Shaking culture was performed for 18 hours at 900 rpm, 30 ℃ while feeding 0.5 liter per minute.
발효방법: 상기 발효배지를 30리터 용량의 시험발효조에 9리터씩 분주하고 121℃에서 10분간 가압살균한 뒤 냉각하여 2차 종배양액을 약 1.5리터씩 접종한후, 공기를 매분당 2.5리터씩 공급하면서 450 rpm, 31℃에서 배양하였다.Fermentation method: The fermentation broth was dispensed by 9 liters into a 30 liter test fermentation tank, pressurized and sterilized at 121 ° C. for 10 minutes, cooled, and inoculated with about 1.5 liters of the secondary seed culture solution, followed by 2.5 liters of air per minute. Incubation was performed at 450 rpm and 31 ° C. while feeding.
상기 조건으로 배양하여 대수증식기 초기 내지 말기 사이에 페니실린 혹은 계면활성제를 첨가하고 배양하며, 배양중 발효액의 pH는 28암모니아수로 pH 7.7이 되도록 계속 조절하였다. 배양중 잔당의 농도가 1.5가 되면, 살균된 폐당밀 또는 폐당밀과 원당을 일정한 비율로 혼합한 당을 수시로 공급하였다. 추가된 당밀 또는 혼합당과 초기의 발효배지에 첨가된 당의 합계가 발효액량 대비 22가 될 때까지 배양을 계속하였다. 배양완료 후 글루탐산의 농도는 KFCC-10656이 108.6 g/l, SM5가 118.4 g/l이었다.Cultivation was carried out under the above conditions, and then cultured with penicillin or a surfactant added between the beginning and the end of the logarithmic phase, and the pH of the fermentation broth during the culture was continuously adjusted to pH 7.7 with 28 ammonia water. When the concentration of the residual sugar in the culture was 1.5, sugars which were mixed with sterilized waste molasses or waste molasses and raw sugar in a constant ratio were frequently supplied. Incubation was continued until the sum of added molasses or mixed sugar and sugar added to the initial fermentation broth was 22 relative to the amount of fermentation broth. After incubation, the concentration of glutamic acid was 108.6 g / l for KFCC-10656 and 118.4 g / l for SM5.
본 발명에 따른 코리네박테리움 글루타미컴 SM5는 글루탐산 생산능이 향상된 균주로서 이를 폐당밀, 포도당, 전분 가수분해물 및 원당 등이 포함된 배지에서 배양하여 글루탐산을 고수율로 제조할 수 있다.Corynebacterium glutamicum SM5 according to the present invention can be produced in high yield by culturing in a medium containing glutamate, glucose, starch hydrolyzate and raw sugar as a strain having improved glutamic acid production ability.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990053495A KR100317902B1 (en) | 1999-11-29 | 1999-11-29 | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1019990053495A KR100317902B1 (en) | 1999-11-29 | 1999-11-29 | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20010048697A KR20010048697A (en) | 2001-06-15 |
KR100317902B1 true KR100317902B1 (en) | 2001-12-24 |
Family
ID=19622410
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019990053495A KR100317902B1 (en) | 1999-11-29 | 1999-11-29 | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR100317902B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101138289B1 (en) * | 2009-09-29 | 2012-04-24 | 대상 주식회사 | Microorganism having glutamic acid-producing activity and process for producing glutamic acid using the same |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR102277404B1 (en) * | 2021-01-27 | 2021-07-14 | 씨제이제일제당 주식회사 | Novel galactoside O-acetyltransferase variant and a method for producing L-glutamic acid using the same |
-
1999
- 1999-11-29 KR KR1019990053495A patent/KR100317902B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101138289B1 (en) * | 2009-09-29 | 2012-04-24 | 대상 주식회사 | Microorganism having glutamic acid-producing activity and process for producing glutamic acid using the same |
Also Published As
Publication number | Publication date |
---|---|
KR20010048697A (en) | 2001-06-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101117022B1 (en) | A microorganism having enhanced l-valine production and process for preparing l-valine using the same | |
KR100429925B1 (en) | Microorganism overproducing 5’-xanthylic acid | |
KR100292299B1 (en) | Microorganism producing glutamic acid and process for preparation glutamic acid using the same | |
KR100317902B1 (en) | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism | |
US7608435B2 (en) | Microorganism producing 5′-xanthylic acid | |
KR100402320B1 (en) | A microorganism Corynebacterium ammoniagenes NV4-82-9 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same | |
KR100317901B1 (en) | A microorganism producing glutamic acid and a method for producing glutamic acid using said microorganism | |
US7456010B2 (en) | Microorganism producing 5′-xanthylic acid | |
JP4177334B2 (en) | Microorganism producing 5'-xanthylic acid | |
RU2096461C1 (en) | Yeast strain yarrowia lipolytica - producer of citric acid and method of citric acid production | |
KR100402322B1 (en) | A microorganism Corynebacterium ammoniagenes CJXP002 being capable of producing 5'-xanthylic acid in higher yield and a producing method of 5'-xanthylic acid by using the same | |
KR100264740B1 (en) | A microorganism producing glutamic acid and a producing method of the glutamic acid using the same | |
KR20010089979A (en) | 5'-Xanthylic acid producing microorganism | |
KR20010089981A (en) | 5'-Xanthylic acid producing microorganism | |
KR100292298B1 (en) | Microorganism producing glutamic acid and process for preparation glutamic acid using the same | |
KR900007948B1 (en) | Novel microorganism for producing of glutamic acid | |
KR900007946B1 (en) | Novel microorganism for producing of glutamic acid | |
WO2006059877A1 (en) | Microorganism producing 5'-xanthylic acid and production method of 5'-xanthylic acid using the same | |
KR900007947B1 (en) | Novel microorganism for producing of glutamic acid | |
KR900007942B1 (en) | Novel microorganism for producing of glutamin acid | |
KR900007938B1 (en) | Novel microorganism for producing of glutamic acid | |
KR100868330B1 (en) | A method for preparing L-threonine | |
KR100429926B1 (en) | Microorganism overproducing 5’-xanthylic acid | |
KR900007943B1 (en) | Novel microorganism for producing of glutamic acid | |
KR900007941B1 (en) | Novel microorganism for producing of glutamic acid |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20120917 Year of fee payment: 12 |
|
FPAY | Annual fee payment |
Payment date: 20130829 Year of fee payment: 13 |
|
FPAY | Annual fee payment |
Payment date: 20140902 Year of fee payment: 14 |
|
FPAY | Annual fee payment |
Payment date: 20150828 Year of fee payment: 15 |
|
FPAY | Annual fee payment |
Payment date: 20160830 Year of fee payment: 16 |
|
FPAY | Annual fee payment |
Payment date: 20170825 Year of fee payment: 17 |
|
FPAY | Annual fee payment |
Payment date: 20180829 Year of fee payment: 18 |